Curriculum

lungs curriculum and resources

Appendix
Curriculum
Goals and Objectives

 

Curriculum number order
ANATOMY, NORMAL VARIANTS: 5%-10% 001
lobar Anatomy 001.1
segmental anatomy 001.2
azygous lobe 001.3
bronchi 001.4
mediastinum 001.5
PNEUMONIA: 5%-10% 002
pneumonia immunocompetent 002.1
pneumonia immunocompromised 002.2
TB 002.3
fungal 002.4
Viral 002.5
septic emboli 002.6
BRONCHOGENIC CANCER: 5%-10% 003
staging 003.1
treatment 003.2
single pulmonary nodule 003.3
screening 003.4
perception 003.5
diagnostic approach 003.6
persistent consolidation 003.7
OTHER TUMORS: UP TO 5% 004
metastases 004.1
carcinoid 004.2
lymphoma 004.3
hamartoma 004.4
LINES, TUBES, DEVICES AND CARDIOVASCULAR RADIOGRAPHY: UP TO 5% 005
central lines 005.1
ETT 005.2
chest tubes 005.3
NG tubes 005.4
PA line 005.5
pneumoperitoneum 005.6
cardiac devices 005.7
TRAUMA: 5%-10% 006
pneumothorax 006.1
pneumomediastinum 006.2
bronchial injury 006.3
hemothorax 006.4
diaphragmatic injury 006.5
flail chest 006.6
fractures 006.7
aorta 006.8
CONGENITAL LUNG/MEDIASTINAL DISEASE: UP TO 5% 007
Poland 007.
cysts 007.1
atresia 007.2
AVM 007.3
PAPVR 007.4
persistent LSVC 007.5
Swyer James 007.6
sequestration 007.7
congenital cystic adenomatoid malformations 007.8
INTERSTITIAL LUNG DISEASE: 5%-10% 008
cystic lung disease 008.1
pneumoconioses 008.2
fibrosis 008.3
CHF 008.4
drug toxicity 008.5
lymphangioleiomyomatosis 008.6
  008.7
  008.7
  008.7
  008.7
sarcoidosis 008.7
ALVEOLAR LUNG DISEASE/INFLAMMATORY: UP TO 5% 009
pulmonary alveolar proteinosis 009.1
lipoid pneumonia 009.2
cyptogenic organizing pneumonia 009.3
pulmonary intestitial emphysema 009.4
hypersensitivy pneumonitis 009.5
CENTRAL AIRWAYS/BRONCHIECTASIS: UP TO 5% 010
tracheal tumors 010.1
aspiration pneumonia 010.10
cystic fibrosis 010.2
stenosis 010.3
immotile cilia 010.4
malacia 010.5
small airways disease
Small airways disease
010.6
Mycobacterium intracellulare (MAI) Mycobacterium avium complex (MAC) (TB) 010.7
Bronchiolithiasis 010.8
allergic bronchopulmonary aspergillosis (ABPA) 010.9
PULMONARY MANIFESTATIONS OF SYSTEMIC DISEASE: UP TO 5% 011
rheumatoid arthritis 011.1
collagen vascular disease 011.2
pulmonary/renal syndromes 011.3
hepatopulmonary syndrome 011.4
vasculitis 011.5
PLEURA, DIAPHRAGM AND CHEST WALL: UP TO 5% 012
mesothelioma 012.1
hernia 012.10
paralysis 012.11
neurofibromatosis 012.12
chest wall tumors
13. Mediastinal masses: up to 5
chest wall tumors
012.13
metastases 012.2
empyema 012.3
pneumothorax 012.4
lipoma 012.5
fibrous tumors of the pleura 012.6
plaque 012.7
effusion 012.8
opacification 012.9
MEDIASTINAL MASSES: UP TO 5% 013
superior mediastinal mass 013.1
anterior mediastinal mass 013.2
middle mediastinal mass 013.3
posterior mediastinal mass 013.4
fibrosing mediastinitis 013.5
vascular disorder causing a mass 013.7
varices 013.8
ATELECTASIS AND COLLAPSE: UP TO 5% 014
lobar collapse 014.1
round atelectasis 014.2
Golden S sign 014.3
whole lung collapse 014.4
PULMONARY ARTERIES: UP TO 5% 015
pulmonary embolism mimics (PE) 015.
acute pulmonary embolism (PE) 015.1
chronic pulmonary embolism (PE) 015.2
Pulmonary infarct 015.3
vasculitis 015.4
pseudoaneurysm 015.5